What if you could generate an entire professional deck in minutes? Enter AI-powered presentation makers. These tools are ...

A Glocester, Rhode Island farm discovered their well water is contaminated with PFAS, or "forever chemicals," at levels ten ...

Discover how Matt Haycox bridges the funding gap by connecting entrepreneurs with capital for their growth plans.

Challenges with data quality and data governance have plagued healthcare analytics efforts for decades – and the stakes are only getting higher in the age of AI. Inaccurate or inconsistent data ...

Kirby Corporation (NYSE:KEX) presented strong second quarter 2025 results during its earnings conference call on July 31, 2025, reporting a 17% year-over-year increase in earnings per share despite ...

RADNOR, Pa. and SOUTH SAN FRANCISCO, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Quanta Therapeutics, a privately-held clinical-stage biopharmaceutical company leading the development of innovative, ...

SOUTH SAN FRANCISCO, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the “Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline ...

SAN DIEGO, Oct. 13, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that ...

JADE101 is an investigational, potentially best-in-class disease-modifying anti-APRIL monoclonal antibody, with a Phase 1 healthy volunteer study underway SAN FRANCISCO and VANCOUVER, British Columbia ...

The Texas-based company announced on Tuesday that its research collaborators will present preclinical data at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer ...

WATERTOWN, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the ...